ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AVO Advanced Oncotherapy Plc

1.925
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Advanced Oncotherapy Plc LSE:AVO London Ordinary Share GB00BD6SX109 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1.925 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Medical Laboratories 0 -29.49M -0.0549 -0.35 10.32M
Advanced Oncotherapy Plc is listed in the Medical Laboratories sector of the London Stock Exchange with ticker AVO. The last closing price for Advanced Oncotherapy was 1.93p. Over the last year, Advanced Oncotherapy shares have traded in a share price range of 1.875p to 8.50p.

Advanced Oncotherapy currently has 537,481,209 shares in issue. The market capitalisation of Advanced Oncotherapy is £10.32 million. Advanced Oncotherapy has a price to earnings ratio (PE ratio) of -0.35.

Advanced Oncotherapy Share Discussion Threads

Showing 3426 to 3447 of 5650 messages
Chat Pages: Latest  142  141  140  139  138  137  136  135  134  133  132  131  Older
DateSubjectAuthorDiscuss
06/3/2017
18:18
Yes, waterloo, I fear there is a serious danger of that happening.
vatnabrekk
06/3/2017
17:12
I'm amazed that they are still going ahead with this strategy based on Harley Street. It was and remains nuts with the companies 'lifeline' is not in their own control but with the builders. Builders!

The BOD are too embedded and pumped by their own importance and jobs for the boys. When this gets taken over by it's lenders, they will sell the tech (hopefully working by then) to Thales or Siemens and will make a good turn. Shareholders will see nowt.

waterloo01
06/3/2017
16:53
I cant really believe them anymore with so many missed targets, even as late as nov 16 they were saying building work at Harley St would only be completed by march 18.
FROM RNS'S
rns 03/06/13
The development of the LIGHT machines is expected to be completed within the next three years with the first new LIGHT machine being delivered in 2016.
The Board of AVO expects that the collaboration could result in significant multi-million pound revenues for the Company, with delivery of the centres targeted from 2016.
rns 14/07/14

This is another significant step towards achieving our goal of delivering and installing our first LIGHT system at the beginning of 2016.
rns 29/09/14
Early milestones met to ensure the delivery of the first system in 2016
rns 28/01/15
Work will start in July 2015, with the property expected to be handed over to Advanced Oncotherapy by the end of 2016 when the first LIGHT System will be ready, enabling patients to start treatments in 2017.
rns 19/05/15
with the first unit expected to be installed in Harley Street, London, by the end of 2016 and first patient treatments expected in 2017
final results 03/06/15
The Company remains on track to install its first unit in Harley Street by the end of 2016 with first patient treatment expected in 2017.
rns 28/07/15
The additional planning permission and reconfiguration of the original site plans will have an impact on the start date for work on the site, however the Company remains on schedule in its technology development to have its first LIGHT system ready for patient treatment in 2017.
RNS 30/11/16
As announced in the update on 24 November 2016 following the granting of planning permission on 19 October 2016, building work at Harley Street is expected to start in early January 2017 and complete by March 2018.

cosmicboy
06/3/2017
16:47
What a disaster.

Everything is significantly delayed which means at the mercy of the finance sharks.

Whats the point going to the presentation - what more does one need than the rns.

twirl
06/3/2017
15:52
Wimpole St. is rather a long way for me (Suffolk) but one of my daughters is going to the presentation and will report back tonight. What will we learn ? share price up tomorrow perhaps ?
altom
06/3/2017
15:51
So Harley St expected to open the same time as UCL Hospital 15mins walk away hmmm. Well its going to need all the CLN and much much more to get to this point, by which time it will have gone bust and some large medical device company will do a pre-pack with the administrator.
smithless
06/3/2017
15:46
Ouch! Come back next decade then!
Will one day be very good tech and cure a lot of patients, but doubt current investors will share in the spoils.

igbertsponk
06/3/2017
15:39
I was too generous re timescales. Now aiming 1st half 2020. Testing complete 3d Q 2018! The funding to get there is not mentioned.

I remain of the view that this might be interesting, but only once they have a fully tested and working model, ie end 2018, if they are still going.

waterloo01
06/3/2017
14:52
And/or they can't get 'the borrow', ie they can't cover long positions by borrowing the shares- often the case with small caps.
scantrader
06/3/2017
14:48
Thanks for that savvy. It is useful to know.

It's an interesting price rise but I suspect it might not last because of the issues with Bracknor. I hope I'm wrong.

daijavu
06/3/2017
14:33
daijavu; not being able to short means there aren't enough buyers. I imagine that will change today as the price has risen quite sharply, although no idea why. Financial spreadbetters will only take a short if they have traders who are long.
1savvyinvestor
06/3/2017
14:04
I see AVO have a CLN spreadsheet in its investors options list. It has issued on conversion of 179,410, but has 302,325 issued warrants. Can someone explain? It has only converted £100k, so it looks like its getting its warrants at 0.33p. Its going to have a load of warrants at this rate.
smithless
06/3/2017
12:07
What is the significance of not being able to short?
daijavu
06/3/2017
12:03
You would have thought the management would have called a GM date by now.
smithless
06/3/2017
10:52
Can't short at Spreader anymore.
wiseacre
02/3/2017
08:46
Don't imagine Directors are allowed to trade (not that that usually stops them) until they've outlined the timetable and how they're going to finance it.
igbertsponk
01/3/2017
20:37
NO shorts allowed at IG either apparently.

Not a good sign.

andy
01/3/2017
20:20
Director buying seems to have rather dried up since the splurge at £1.00 and then when the share price was in the 60's. One can only assume they too are nervous about the commercial viability of their work and investment which from the outside, hasn't been investable since the news of the delay in planning hit last summer, and all that followed.

What happens, if they survive that long, if they get a working and costed prototype, is a different story, but currently it's a leap of faith, and even the directors are now having second thoughts, but I do keep an eye open, just in case.

waterloo01
01/3/2017
20:08
Anyone going to their investors event next Monday?
seans66
01/3/2017
01:20
Yes I agree - I'm thinking of hedging my position briefly though because if I closed it I doubt I'd be able to re-open it.
This company does have a well developed spinotron !

scantrader
28/2/2017
23:06
Although I think AVO is a massive short, a little caution in the short term is needed as I think management may hype the company at the forthcoming presentations in a few days time
smithless
28/2/2017
17:56
IgbertSponk
28 Feb '17 - 08:25 - 2955 of 2968    0   0
What happens when they (pretty soon I guess) try to issue 25p nominal value shares for less than 25p cash as the conversions continue ?

Igbert, the way I saw another company get around it was they issued conversion shares at the nominal price and then issued a load of "fee" shares for nothing which brought the average price down to whatever it needed to be. That company put resolutions into its AGM to reduce the nominal by a factor of 4. By the end of the death spiral the share price had cratered so much that even at the new lower nominal they were issuing more shares as "fee" shares than they were issuing on conversion.

sweet karolina
Chat Pages: Latest  142  141  140  139  138  137  136  135  134  133  132  131  Older

Your Recent History

Delayed Upgrade Clock